NVDA vs TSEM

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.

TSEM exhibits a stable financial health profile with a Piotroski F-Score of 4/9 and an exceptionally strong balance sheet characterized by negligible debt. However, the stock is severely overvalued, trading at $224.49—nearly four times its growth-based intrinsic value of $56.93 and nearly seven times its Graham Number of $33.56. While earnings growth is robust, the P/E of 116.32 and PEG of 5.44 indicate that the current price has far outpaced fundamental growth. The combination of a bearish technical trend (10/100) and a current price significantly above the analyst target of $168.57 suggests a high risk of a correction.